MAGAGNOLI, LORENZA
MAGAGNOLI, LORENZA
Dipartimento di Scienze della Salute
Uremic Toxin‐Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes
2026 R. Fernando Rivera, M. Teresa Sciarrone Alibrandi, N. Edvige Foligno, L. Magagnoli, P. Ciceri, M. Cozzolino
Association between Blood Flow Measured within 30 Days from Arteriovenous Access Creation and Thrombosis Risk
2025 G. Scherini, L. Magagnoli, A. Cara, G. Boni Brivio, I. Barbetta, L. Freni, U. Zoni, D. Curtò, A. Stucchi, M. Crippa, M. Cozzolino
Critical evaluation of therapeutic targeting in chronic kidney disease: where do we stand 5 years on?
2025 M. Cozzolino, L. Magagnoli, P. Ciceri
Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL study
2025 L. Magagnoli, M. Cozzolino, F.J. Caskey, C. Torino, F.W. Dekker, M. Evans, M. Szymczak, C. Wanner, M. Pippias, C. Drechsler, A. Vilasi, E. Driehuis, P. Stenvinkel, V.S. Stel, K.J. Jager, N.C. Chesnaye
MCO Membranes and FGF-23: Advancing Dialysis Strategies for Better Outcomes?
2025 S. Barbuto, L. Magagnoli, G. Cianciolo, G. La Manna, M. Cozzolino, P. Ciceri
Calciprotein Particles in CKD: When Good Molecules Go Bad
2025 L. Magagnoli, M. Cozzolino
From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research
2025 M. Cozzolino, L. Magagnoli, P. Ciceri
Vitamin D: are all compounds equal?
2025 L. Magagnoli, M. Cassia, A. Galassi, P. Ciceri, E. Massò, R. Gelpi, J. Bover, M. Cozzolino
Inibitori dell’enzima prolil-idrossilasi del fattore inducibile da ipossia: una nuova terapia per l’anemia nei pazienti con insufficienza renale cronica
2024 A. Stucchi, L. Magagnoli, A. Cara, M. Cozzolino
Angiopoietin as A Novel Prognostic Marker in Kidney Disease
2024 A.B. Yildiz, S. Copur, C. Tanriover, F. Yavuz, S. Vehbi, A. Gaipov, L. Magagnoli, P. Ciceri, M. Cozzolino, M. Kanbay
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease : Results from the EQUAL Study
2024 L. Magagnoli, M. Cozzolino, M. Evans, F.J. Caskey, F.W. Dekker, C. Torino, M. Szymczak, C. Drechsler, M. Pippias, A. Vilasi, R.J. Janse, M. Krajewska, V.S. Stel, K.J. Jager, N.C. Chesnaye
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, Current treatments and investigational drugs
2024 L. Magagnoli, P. Ciceri, M. Cozzolino
The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?
2023 L. Magagnoli, M. Cozzolino, A. Galassi
Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
2023 L. Magagnoli, M. Cozzolino, F. J Caskey, M. Evans, C. Torino, G. Porto, M. Szymczak, M. Krajewska, C. Drechsler, P. Stenvinkel, M. Pippias, F. W Dekker, E.N. M de Rooij, C. Wanner, N. C Chesnaye, K. J Jager
Future treatment of vascular calcification in chronic kidney disease
2023 M. Cozzolino, F. MAFFEI FACCIOLI, A. Cara, G. BONI BRIVIO, F. Rivela, P. Ciceri, L. Magagnoli, A. Galassi, S. Barbuto, S. Speciale, C. Minicucci, G. Cianciolo
Intrauterine life to adulthood: a potential risk factor for chronic kidney disease
2023 M. Kanbay, S. Copur, A.B. Yildiz, A. Covic, A. Covic, P. Ciceri, L. Magagnoli, M. Cozzolino
Choice of the Dialysis Modality: Practical Considerations
2023 M. Torreggiani, G.B. Piccoli, M.R. Moio, F. Conte, L. Magagnoli, P. Ciceri, M. Cozzolino
Beyond vessels and bones: can CKD-MBD treatment improve uremic subjects' minds?
2022 L. Magagnoli, A. Galassi, M. Cozzolino
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
2022 P. Ciceri, V. Bono, L. Magagnoli, M. Sala, A. D'ARMINIO MONFORTE, A. Galassi, A. Barassi, G.C. Marchetti, M.G. Cozzolino
Measuring FGF23 in clinical practice: dream or reality?
2022 L. Magagnoli, A. Galassi, P. Ciceri, M. Cozzolino